tiprankstipranks
Ikena Oncology (IKNA)
NASDAQ:IKNA
US Market

Ikena Oncology (IKNA) Technical Analysis

Compare
98 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
2Neutral
14Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Ikena Oncology’s (IKNA) Moving Averages Convergence Divergence (MACD) indicator is -0.04, suggesting Ikena Oncology is a Buy.
Ikena Oncology’s (IKNA) 20-Day exponential moving average is 1.43, while Ikena Oncology’s (IKNA) share price is $1.29, making it a Sell.
Ikena Oncology’s (IKNA) 50-Day exponential moving average is 1.50, while Ikena Oncology’s (IKNA) share price is $1.29, making it a Sell.

Ikena Oncology (IKNA) Pivot Points

Mar 04, 2025, 03:27 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.30
1.32
1.35
1.37
1.40
1.42
1.45
Fibonacci
1.32
1.34
1.35
1.37
1.39
1.40
1.42
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Ikena Oncology (IKNA) Moving Averages

Mar 04, 2025, 03:27 PM
Period
Simple
Exponential
MA5
1.37Sell
1.37Sell
MA10
1.41Sell
1.40Sell
MA20
1.43Sell
1.43Sell
MA50
1.51Sell
1.50Sell
MA100
1.61Sell
1.56Sell
MA200
1.63Sell
1.56Sell
Ikena Oncology’s (IKNA) 10-Day exponential moving average is 1.40, while Ikena Oncology’s (IKNA) share price is $1.29, making it a Sell.
Ikena Oncology’s (IKNA) 100-Day exponential moving average is 1.56, while Ikena Oncology’s (IKNA) share price is $1.29, making it a Sell.
Ikena Oncology’s (IKNA) stock price is $1.29 and Ikena Oncology’s (IKNA) 50-day simple moving average is 1.51, creating a Sell signal.
Ikena Oncology’s (IKNA) stock price is $1.29 and Ikena Oncology’s (IKNA) 100-day simple moving average is 1.61, creating a Sell signal.
Ikena Oncology’s (IKNA) stock price is $1.29 and Ikena Oncology’s (IKNA) 200-day simple moving average is 1.63, creating a Sell signal.

Ikena Oncology (IKNA) Technical Indicators

Mar 04, 2025, 03:27 PM
Name
Value
Implied Action
RSI (14)
31.44
Neutral
STOCH (9,6)
16.71
Buy
STOCHRSI (14)
14.32
Buy
MACD (12,26)
-0.04
Buy
ADX (14)
17.37
Buy
Williams %R
-86.67
Buy
CCI (14)
-202.27
Buy
ATR (14)
0.07
-
Ultimate Oscillator
35.91
Neutral
ROC
-6.94
Sell
Ikena Oncology’s (IKNA) Relative Strength Index (RSI) is 31.44, creating a Neutral signal.
Ikena Oncology’s (IKNA) Trend Strength Indicator (ADX) is 17.37, creating a Buy signal.
Ikena Oncology’s (IKNA) Commodity Channel Index (CCI) is -202.27, creating a Buy signal.
Ikena Oncology’s (IKNA) Price Rate of Change (ROC) is -6.94, creating a Sell signal.

FAQ

Is IKNA a Buy, Hold, or Sell?
Based on IKNA’s technical indicators, IKNA is a Sell.
    What is IKNA’s RSI (14)?
    IKNA’s RSI (14) is 31.44, which suggests IKNA is a Neutral.
      What is IKNA’s MACD?
      IKNA’s MACD is -0.04, which suggests IKNA is a Buy.
        What is IKNA’s 5-day moving average?
        IKNA’s 5-day moving average is 1.37, which suggests IKNA is a Sell.
          What is IKNA’s 20-day moving average?
          IKNA 20-day moving average is 1.43, which suggests IKNA is a Sell.
            What is IKNA’s 50-day moving average?
            IKNA’s 50-day moving average is 1.51, which suggests IKNA is a Sell.
              What is IKNA’s 200-day moving average?
              IKNA’s 200-day moving average is 1.63, which suggests IKNA is a Sell.
                What is IKNA’s Williams % R (14)?
                IKNA’s Williams % R (14) is -86.67, which suggests IKNA is a Buy.
                  What is IKNA’s CCI (14)?
                  IKNA’s CCI (14) is -202.27, which suggests IKNA is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis